Myeloma treatment cost in Thailand typically includes a consultation with an oncohematologist for AUD $145 / ฿A4,932 – AUD $290 / ฿A9,864 and essential blood tests. Patients find that advanced therapy and monitoring in Bangkok generally cost 40% to 80% less than in Australia. Total expenses depend on the clinical stage, specific drug protocols, and hospital choice. Bangkok serves as the primary hub for this specialised care.
Typical Myeloma Treatment Costs in Thailand
Bookimed Expert Insight: For complex cases, JCI-accredited facilities like Bumrungrad International Hospital offer high-tech cancer centres. They manage over one million patients annually, providing deep experience in hematology. Patients seeking alternative options might consider Panacee Hospital Rama 2. It offers integrative cellular treatments alongside modern medicine. Specialists like Dr. Kodchanut Litleaungdej provide board-certified expertise for patients needing precise diagnostic validation.
| Thailand | Turkey | South Korea | |
| Plasmapheresis | from AUD $3,191 / ฿A108,506 | from AUD $1,741 / ฿A59,185 | from AUD $6,093 / ฿A207,148 |
| Therapeutic Apheresis | - | from AUD $1,958 / ฿A66,583 | - |
| Plasma Exchange | - | from AUD $5,657 / ฿A192,351 | - |
| DFPP Plasmapheresis | - | from AUD $2,684 / ฿A91,244 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Myeloma treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Myeloma treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Myeloma treatment journey.
Dr Litleaungdej graduated with honours from Naresuan University and holds a Thai Board certification in haematology. She practiced at Thammasat University Hospital, a major academic centre with a specialised haematology unit.
Thailand offers multiple myeloma treatment comparable to Western countries. Top hospitals like Bumrungrad International hold Joint Commission International (JCI) accreditation. They provide advanced care including stem cell therapy and specialised haematology consultations. Outcomes and technology match Western standards at significantly lower costs.
Bookimed Expert Insight: Thailand’s major hospitals treat nearly 1,000,000 patients annually, showing high capacity. Bumrungrad International features 1,300 doctors across 70 departments, reflecting diverse expertise. Panacee Hospital Rama 2 combines regenerative and chronic disease treatments, welcoming integrative therapies alongside standard myeloma care.
Patient Consensus: Patients appreciate clear symptom relief and friendly care in Thailand. Australians highlight effective radiation and pain management, plus helpful English support. Some note stem cell therapy results vary, so managing expectations about experimental treatments matters.
Common multiple myeloma treatments in Thailand include stem cell transplants, targeted drugs, chemotherapy, and radiation. Leading hospitals use immunomodulatory drugs like lenalidomide and proteasome inhibitors such as bortezomib. Stem cell transplantation follows induction therapy for eligible patients, improving long-term control.
Bookimed Expert Insight: Stem cell transplant remains key but some patients avoid it due to isolation and language concerns. Bumrungrad International Hospital in Bangkok has advanced equipment and English-speaking staff, easing treatment for Australians. Experimental regenerative therapies exist but lack robust proof, so standard drug and transplant combos remain the go-to approach.
Patient Consensus: Patients in Thailand note pain relief often comes after a few chemo cycles with drugs like Velcade. Isolation during stem cell transplant is tough but manageable with English support. Radiation helps with bone pain, letting patients stay mobile during treatment.
Autologous stem cell transplants for multiple myeloma in Thailand follow global protocols. Patients undergo stem cell collection, high-dose chemotherapy, then stem cell reinfusion. Leading centres include Bumrungrad International Hospital, which offers JCI accreditation and English-speaking staff. Panacee Hospital Rama 2 provides regenerative cell therapy but is not a standard myeloma transplant centre.
Bookimed Expert Insight: Thailand's top transplant centre, Bumrungrad, combines JCI accreditation with telemedicine and English interpreters. This makes care accessible and safer for international patients. Meanwhile, some regenerative clinics promoting stem cell therapies for myeloma are not evidence-based and have faced legal issues. Australians should prioritise hospitals with proven international protocols.
Patient Consensus: Patients note Thailand offers skilled specialists and clear communication in English. Many stress the importance of proper hospital accreditation and warn about confusing regenerative clinics with standard transplants. Those who used recognised transplant centres highlight good hospital care and infection safety.
Advanced diagnostic tests for multiple myeloma are available in Thailand, especially in Bangkok. Leading hospitals offer blood tests, bone marrow biopsy, and imaging like PET/CT and MRI. Genetic testing such as FISH is accessible to help guide treatment.
Bookimed Expert Insight: Thailand’s top hospitals combine global-standard diagnostics with integrative therapies. Panacee Hospital Rama 2 offers cell therapies alongside diagnostics, while Bumrungrad handles over 1 million patients yearly, providing robust imaging and genetic tests. Australians should bring their previous results to avoid repeat tests.
Patient Consensus: Patients note that Thai hospitals follow international myeloma diagnostic steps, including comprehensive imaging and biopsies. They advise confirming availability of advanced genetic tests before travel. Many appreciate combining diagnostics with targeted treatments at private Bangkok clinics.
Top multiple myeloma specialists in Bangkok are at Bumrungrad International Hospital and Panacee Hospital Rama 2. Bumrungrad is JCI-accredited, sees over 1 million patients yearly, and offers expert haematology and oncology care. Panacee combines cell therapy with regenerative medicine.
Bookimed Expert Insight: Bumrungrad International leverages its large patient volume and global accreditations to serve Australians well. Panacee Hospital offers complementary cell therapy options rarely found in standard myeloma care. Australians benefit from Bumrungrad's English-speaking staff and direct insurance billing, easing treatment logistics.
Patient Consensus: Patients highlight Bangkok Hospital group’s top myeloma care and advanced tech like proton therapy. Many value private centres’ English support, but recommend arranging translation for smaller hospitals. Siriraj Hospital doctors set high standards and often work with private clinics for best care.
International patients can access multiple myeloma treatment easily in Thailand, especially at JCI-accredited hospitals like Bumrungrad International. These hospitals offer advanced therapies including stem cell transplants and have English-speaking staff. Thailand’s medical tourism infrastructure supports international patients well.
Bookimed Expert Insight: Thailand’s top hospitals like Bumrungrad excel in serving international patients with multiple myeloma. Their large patient volumes and international accreditations mean smoother processes and expert care. Though stem cell transplant protocols include isolation phases, familiar hospitals offer better support and interpreter services.
Patient Consensus: Patients note Thailand’s big hospitals ease language and logistics challenges. Bringing translated medical records is vital to avoid delays. The medical visa options suit multi-step treatments, and the care feels well organised for international travellers.